Last reviewed · How we verify

NCT04769557

Pre Emptive Analgesics for Pain Relief in Impacted Lower Third Molar Surgery

Completed Phase 4 Last updated 24 February 2021
What this trial tests

Phase 4 trial testing paracetamol in Impacted Third Molar Tooth in 60 participants. Completed in 27 February 2019.

Timeline
4 March 2017
Primary endpoint
27 February 2019
27 February 2019

Quick facts

Lead sponsorMelaka Manipal Medical College
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date4 March 2017
Primary completion27 February 2019
Estimated completion27 February 2019
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Melaka Manipal Medical College

Who can join

21 and older, any sex, with Impacted Third Molar Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the efficacy of pre-emptive paracetamol in reducing intra operative pressure and post operative pain after surgical removal of impacted mandibular third molar using visual analogue scale

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of paracetamol

Trials testing the same drug.

Other recruiting trials for Impacted Third Molar Tooth

Currently open trials in the same condition.

Other Melaka Manipal Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04769557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing